title: Profile of serum pregnancy-associated plasma protein A after sustained subcutaneous low molecular weight heparin administration in patients with cerebrovascular diseases.
authors.forename: Shun
authors.initials: S
authors.lastname: Wang
authors.forename: Lili
authors.initials: L
authors.lastname: Wang
authors.forename: Xin
authors.initials: X
authors.lastname: Zhang
authors.forename: Chuanxin
authors.initials: C
authors.lastname: Wang
authors.forename: Wei
authors.initials: W
authors.lastname: Wu
authors.forename: Xuhua
authors.initials: X
authors.lastname: Zhang
authors.forename: Zhaogang
authors.initials: Z
authors.lastname: Dong
authors.forename: Lutao
authors.initials: L
authors.lastname: Du
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D002341:Carotid Artery Thrombosis / Q000097:blood / Q000517:prevention & control; D002851:Chromatography, High Pressure Liquid; D003692:Delayed-Action Preparations; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D011266:Pregnancy-Associated Plasma Protein-A / Q000032:analysis*; D020521:Stroke / Q000097:blood / Q000188:drug therapy* / Q000517:prevention & control; D013997:Time Factors
chemical_list: D000925:Anticoagulants; D015415:Biomarkers; D003692:Delayed-Action Preparations; D006495:Heparin, Low-Molecular-Weight; D011266:Pregnancy-Associated Plasma Protein-A